
RSUs vs. Stock Options: A Life Sciences Founder’s Guide
The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your

The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your

Building a tech or biotech startup requires assembling a world-class team. To attract top-tier engineers, clinical scientists, and seasoned executives,

Summary for Founders Use stock options to conserve cash and retain talent Set the exercise price at fair market value